P-1753. Impact of a Microbiology Reporting Change on Treatment Selection and Clinical Outcomes for Organisms at Low-Risk for Significant AmpC Production Article Swipe
Elizabeth Hodapp
,
Patrick Kinn
,
Bradley Ford
,
Sarah Auerbach
,
Lukasz Weiner
,
Dilek İnce
,
Amy M. J. O’Shea
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1093/ofid/ofae631.1916
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1093/ofid/ofae631.1916
Background AmpC β-lactamase production can be induced after exposure to beta lactam antimicrobials, most notably ceftriaxone (CRO), leading to development of resistance on therapy. New guidance from IDSA indicates that the risk of AmpC enzyme production is not equal among all Enterobacterales and those deemed low-risk may be treated with CRO. The purpose of this study was to evaluate the impact of a microbiology reporting change made in collaboration with our antimicrobial stewardship program (ASP) to guide antibiotic selection for low-risk AmpC organisms. Methods This was a pre-test, post-test quasi-experimental study with data collected by chart review. A microbiology comment warning against the potential for inducible resistance on therapy with CRO was present pre-test and was removed in the post-test period. A didactic education session was given by ASP to medicine services. The study enrolled hospitalized patients ≥1 month old treated for infection with a low-risk AmpC organism (Serratia marcescens, Morganella morganii, Proteus vulgaris, and Providencia spp.) pre- (3/21-2/22) and post-intervention (8/22-7/23). Further inclusion and exclusion criteria are in table 1. The primary outcome was rate of carbapenem-sparing definitive treatment. Secondary outcomes were rate of CRO definitive therapy along with 30-day readmission, retreatment, mortality, and development of CRO resistance. Results 73 patients were included: 36 (49%) pre- and 37 (51%) post-intervention. Patient, infection, and treatment characteristics are described in table 2.Serratia marcescens was the most common organism isolated with the most frequent sources being respiratory and urinary. There was no significant difference in the rate of carbapenem-sparing therapy between the pre- (83%) and post-(81%) intervention, p=0.59. No difference was found in CRO as definitive therapy in either group (25% vs. 33%, p=0.49) as well. No difference was seen in secondary clinical outcomes (table 3). For those with repeat positive cultures within 30 days, none developed CRO resistance. Conclusion The combination of changing microbiology reporting and a single ASP education session did not change antibiotic selection for low-risk AmpC producing organisms. Despite updated guidance the uptake in practice is slow. Disclosures All Authors: No reported disclosures
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/ofid/ofae631.1916
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4406945388
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4406945388Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ofid/ofae631.1916Digital Object Identifier
- Title
-
P-1753. Impact of a Microbiology Reporting Change on Treatment Selection and Clinical Outcomes for Organisms at Low-Risk for Significant AmpC ProductionWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-01-29Full publication date if available
- Authors
-
Elizabeth Hodapp, Patrick Kinn, Bradley Ford, Sarah Auerbach, Lukasz Weiner, Dilek İnce, Amy M. J. O’SheaList of authors in order
- Landing page
-
https://doi.org/10.1093/ofid/ofae631.1916Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1093/ofid/ofae631.1916Direct OA link when available
- Concepts
-
Medicine, Clinical microbiology, Selection (genetic algorithm), Microbiology, Intensive care medicine, Biology, Artificial intelligence, Computer scienceTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4406945388 |
|---|---|
| doi | https://doi.org/10.1093/ofid/ofae631.1916 |
| ids.doi | https://doi.org/10.1093/ofid/ofae631.1916 |
| ids.openalex | https://openalex.org/W4406945388 |
| fwci | 0.0 |
| type | article |
| title | P-1753. Impact of a Microbiology Reporting Change on Treatment Selection and Clinical Outcomes for Organisms at Low-Risk for Significant AmpC Production |
| biblio.issue | Supplement_1 |
| biblio.volume | 12 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10206 |
| topics[0].field.id | https://openalex.org/fields/18 |
| topics[0].field.display_name | Decision Sciences |
| topics[0].score | 0.7002999782562256 |
| topics[0].domain.id | https://openalex.org/domains/2 |
| topics[0].domain.display_name | Social Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1804 |
| topics[0].subfield.display_name | Statistics, Probability and Uncertainty |
| topics[0].display_name | Meta-analysis and systematic reviews |
| is_xpac | False |
| apc_list.value | 3064 |
| apc_list.currency | USD |
| apc_list.value_usd | 3064 |
| apc_paid.value | 3064 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3064 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7416906356811523 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2992965680 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7097086310386658 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q598976 |
| concepts[1].display_name | Clinical microbiology |
| concepts[2].id | https://openalex.org/C81917197 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6416826844215393 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q628760 |
| concepts[2].display_name | Selection (genetic algorithm) |
| concepts[3].id | https://openalex.org/C89423630 |
| concepts[3].level | 1 |
| concepts[3].score | 0.45293620228767395 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[3].display_name | Microbiology |
| concepts[4].id | https://openalex.org/C177713679 |
| concepts[4].level | 1 |
| concepts[4].score | 0.3623769283294678 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[4].display_name | Intensive care medicine |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.18635648488998413 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C154945302 |
| concepts[6].level | 1 |
| concepts[6].score | 0.10155549645423889 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11660 |
| concepts[6].display_name | Artificial intelligence |
| concepts[7].id | https://openalex.org/C41008148 |
| concepts[7].level | 0 |
| concepts[7].score | 0.07843104004859924 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[7].display_name | Computer science |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7416906356811523 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/clinical-microbiology |
| keywords[1].score | 0.7097086310386658 |
| keywords[1].display_name | Clinical microbiology |
| keywords[2].id | https://openalex.org/keywords/selection |
| keywords[2].score | 0.6416826844215393 |
| keywords[2].display_name | Selection (genetic algorithm) |
| keywords[3].id | https://openalex.org/keywords/microbiology |
| keywords[3].score | 0.45293620228767395 |
| keywords[3].display_name | Microbiology |
| keywords[4].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[4].score | 0.3623769283294678 |
| keywords[4].display_name | Intensive care medicine |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.18635648488998413 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/artificial-intelligence |
| keywords[6].score | 0.10155549645423889 |
| keywords[6].display_name | Artificial intelligence |
| keywords[7].id | https://openalex.org/keywords/computer-science |
| keywords[7].score | 0.07843104004859924 |
| keywords[7].display_name | Computer science |
| language | en |
| locations[0].id | doi:10.1093/ofid/ofae631.1916 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735126445 |
| locations[0].source.issn | 2328-8957 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2328-8957 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Open Forum Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Open Forum Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1093/ofid/ofae631.1916 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:11777972 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | other-oa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/other-oa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Open Forum Infect Dis |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11777972 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5080573381 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Elizabeth Hodapp |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210142782 |
| authorships[0].affiliations[0].raw_affiliation_string | University of Iowa Health Care , Iowa City, Iowa |
| authorships[0].institutions[0].id | https://openalex.org/I4210142782 |
| authorships[0].institutions[0].ror | https://ror.org/0431j1t39 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I126307644, https://openalex.org/I4210142782 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Iowa Health Care |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ellie Hodapp |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | University of Iowa Health Care , Iowa City, Iowa |
| authorships[1].author.id | https://openalex.org/A5028688215 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2600-1784 |
| authorships[1].author.display_name | Patrick Kinn |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2802216851 |
| authorships[1].affiliations[0].raw_affiliation_string | University of Iowa Hospitals & Clinics , Iowa City, Iowa |
| authorships[1].institutions[0].id | https://openalex.org/I2802216851 |
| authorships[1].institutions[0].ror | https://ror.org/04g2swc55 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I126307644, https://openalex.org/I2802216851 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of Iowa Hospitals and Clinics |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Patrick M Kinn |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | University of Iowa Hospitals & Clinics , Iowa City, Iowa |
| authorships[2].author.id | https://openalex.org/A5034418336 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7871-7955 |
| authorships[2].author.display_name | Bradley Ford |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2802216851 |
| authorships[2].affiliations[0].raw_affiliation_string | University of Iowa Hospitals and Clinics , Iowa City, Iowa |
| authorships[2].institutions[0].id | https://openalex.org/I2802216851 |
| authorships[2].institutions[0].ror | https://ror.org/04g2swc55 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I126307644, https://openalex.org/I2802216851 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of Iowa Hospitals and Clinics |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Bradley A Ford |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | University of Iowa Hospitals and Clinics , Iowa City, Iowa |
| authorships[3].author.id | https://openalex.org/A5011928219 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Sarah Auerbach |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2802216851 |
| authorships[3].affiliations[0].raw_affiliation_string | University of Iowa Hospitals and Clinics , Iowa City, Iowa |
| authorships[3].institutions[0].id | https://openalex.org/I2802216851 |
| authorships[3].institutions[0].ror | https://ror.org/04g2swc55 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I126307644, https://openalex.org/I2802216851 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of Iowa Hospitals and Clinics |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Sarah Auerbach |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | University of Iowa Hospitals and Clinics , Iowa City, Iowa |
| authorships[4].author.id | https://openalex.org/A5056691364 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Lukasz Weiner |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2802216851 |
| authorships[4].affiliations[0].raw_affiliation_string | University of Iowa Hospitals & Clinics , Iowa City, Iowa |
| authorships[4].institutions[0].id | https://openalex.org/I2802216851 |
| authorships[4].institutions[0].ror | https://ror.org/04g2swc55 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I126307644, https://openalex.org/I2802216851 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | University of Iowa Hospitals and Clinics |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Lukasz Weiner |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University of Iowa Hospitals & Clinics , Iowa City, Iowa |
| authorships[5].author.id | https://openalex.org/A5058759387 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5446-3789 |
| authorships[5].author.display_name | Dilek İnce |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2802216851 |
| authorships[5].affiliations[0].raw_affiliation_string | University of Iowa Hospitals & Clinics , Iowa City, Iowa |
| authorships[5].institutions[0].id | https://openalex.org/I2802216851 |
| authorships[5].institutions[0].ror | https://ror.org/04g2swc55 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I126307644, https://openalex.org/I2802216851 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | University of Iowa Hospitals and Clinics |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Dilek Ince |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | University of Iowa Hospitals & Clinics , Iowa City, Iowa |
| authorships[6].author.id | https://openalex.org/A5035762054 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-3272-7952 |
| authorships[6].author.display_name | Amy M. J. O’Shea |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210142782 |
| authorships[6].affiliations[0].raw_affiliation_string | University of Iowa Health Care , Iowa City, Iowa |
| authorships[6].institutions[0].id | https://openalex.org/I4210142782 |
| authorships[6].institutions[0].ror | https://ror.org/0431j1t39 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I126307644, https://openalex.org/I4210142782 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | University of Iowa Health Care |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Kelly M Percival |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | University of Iowa Health Care , Iowa City, Iowa |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1093/ofid/ofae631.1916 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | P-1753. Impact of a Microbiology Reporting Change on Treatment Selection and Clinical Outcomes for Organisms at Low-Risk for Significant AmpC Production |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10206 |
| primary_topic.field.id | https://openalex.org/fields/18 |
| primary_topic.field.display_name | Decision Sciences |
| primary_topic.score | 0.7002999782562256 |
| primary_topic.domain.id | https://openalex.org/domains/2 |
| primary_topic.domain.display_name | Social Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1804 |
| primary_topic.subfield.display_name | Statistics, Probability and Uncertainty |
| primary_topic.display_name | Meta-analysis and systematic reviews |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/ofid/ofae631.1916 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735126445 |
| best_oa_location.source.issn | 2328-8957 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2328-8957 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Open Forum Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Open Forum Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ofid/ofae631.1916 |
| primary_location.id | doi:10.1093/ofid/ofae631.1916 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735126445 |
| primary_location.source.issn | 2328-8957 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2328-8957 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Open Forum Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Open Forum Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1093/ofid/ofae631.1916 |
| publication_date | 2025-01-29 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.A | 98, 122 |
| abstract_inverted_index.a | 63, 87, 145, 306 |
| abstract_inverted_index.1. | 171 |
| abstract_inverted_index.30 | 292 |
| abstract_inverted_index.36 | 205 |
| abstract_inverted_index.37 | 209 |
| abstract_inverted_index.73 | 201 |
| abstract_inverted_index.No | 257, 275, 333 |
| abstract_inverted_index.as | 263, 273 |
| abstract_inverted_index.be | 6, 48 |
| abstract_inverted_index.by | 95, 128 |
| abstract_inverted_index.in | 68, 118, 169, 219, 243, 261, 266, 279, 326 |
| abstract_inverted_index.is | 37, 328 |
| abstract_inverted_index.no | 240 |
| abstract_inverted_index.of | 21, 33, 54, 62, 177, 185, 197, 246, 301 |
| abstract_inverted_index.on | 23, 108 |
| abstract_inverted_index.to | 10, 19, 58, 76, 130 |
| abstract_inverted_index.3). | 284 |
| abstract_inverted_index.ASP | 129, 308 |
| abstract_inverted_index.All | 331 |
| abstract_inverted_index.CRO | 111, 186, 198, 262, 296 |
| abstract_inverted_index.For | 285 |
| abstract_inverted_index.New | 25 |
| abstract_inverted_index.The | 52, 133, 172, 299 |
| abstract_inverted_index.all | 41 |
| abstract_inverted_index.and | 43, 115, 155, 160, 165, 195, 208, 214, 236, 253, 305 |
| abstract_inverted_index.are | 168, 217 |
| abstract_inverted_index.can | 5 |
| abstract_inverted_index.did | 311 |
| abstract_inverted_index.for | 80, 105, 142, 316 |
| abstract_inverted_index.may | 47 |
| abstract_inverted_index.not | 38, 312 |
| abstract_inverted_index.old | 140 |
| abstract_inverted_index.our | 71 |
| abstract_inverted_index.the | 31, 60, 103, 119, 224, 230, 244, 250, 324 |
| abstract_inverted_index.vs. | 270 |
| abstract_inverted_index.was | 57, 86, 112, 116, 126, 175, 223, 239, 259, 277 |
| abstract_inverted_index.(25% | 269 |
| abstract_inverted_index.33%, | 271 |
| abstract_inverted_index.AmpC | 2, 34, 82, 147, 318 |
| abstract_inverted_index.CRO. | 51 |
| abstract_inverted_index.IDSA | 28 |
| abstract_inverted_index.This | 85 |
| abstract_inverted_index.beta | 11 |
| abstract_inverted_index.data | 93 |
| abstract_inverted_index.from | 27 |
| abstract_inverted_index.made | 67 |
| abstract_inverted_index.most | 14, 225, 231 |
| abstract_inverted_index.none | 294 |
| abstract_inverted_index.pre- | 158, 207, 251 |
| abstract_inverted_index.rate | 176, 184, 245 |
| abstract_inverted_index.risk | 32 |
| abstract_inverted_index.seen | 278 |
| abstract_inverted_index.that | 30 |
| abstract_inverted_index.this | 55 |
| abstract_inverted_index.were | 183, 203 |
| abstract_inverted_index.with | 50, 70, 92, 110, 144, 190, 229, 287 |
| abstract_inverted_index.≥1 | 138 |
| abstract_inverted_index.(49%) | 206 |
| abstract_inverted_index.(51%) | 210 |
| abstract_inverted_index.(83%) | 252 |
| abstract_inverted_index.(ASP) | 75 |
| abstract_inverted_index.There | 238 |
| abstract_inverted_index.after | 8 |
| abstract_inverted_index.along | 189 |
| abstract_inverted_index.among | 40 |
| abstract_inverted_index.being | 234 |
| abstract_inverted_index.chart | 96 |
| abstract_inverted_index.days, | 293 |
| abstract_inverted_index.equal | 39 |
| abstract_inverted_index.found | 260 |
| abstract_inverted_index.given | 127 |
| abstract_inverted_index.group | 268 |
| abstract_inverted_index.guide | 77 |
| abstract_inverted_index.month | 139 |
| abstract_inverted_index.slow. | 329 |
| abstract_inverted_index.spp.) | 157 |
| abstract_inverted_index.study | 56, 91, 134 |
| abstract_inverted_index.table | 170, 220 |
| abstract_inverted_index.those | 44, 286 |
| abstract_inverted_index.well. | 274 |
| abstract_inverted_index.(CRO), | 17 |
| abstract_inverted_index.(table | 283 |
| abstract_inverted_index.30-day | 191 |
| abstract_inverted_index.change | 66, 313 |
| abstract_inverted_index.common | 226 |
| abstract_inverted_index.deemed | 45 |
| abstract_inverted_index.either | 267 |
| abstract_inverted_index.enzyme | 35 |
| abstract_inverted_index.impact | 61 |
| abstract_inverted_index.lactam | 12 |
| abstract_inverted_index.repeat | 288 |
| abstract_inverted_index.single | 307 |
| abstract_inverted_index.uptake | 325 |
| abstract_inverted_index.within | 291 |
| abstract_inverted_index.Despite | 321 |
| abstract_inverted_index.Further | 163 |
| abstract_inverted_index.Methods | 84 |
| abstract_inverted_index.Proteus | 153 |
| abstract_inverted_index.Results | 200 |
| abstract_inverted_index.against | 102 |
| abstract_inverted_index.between | 249 |
| abstract_inverted_index.comment | 100 |
| abstract_inverted_index.induced | 7 |
| abstract_inverted_index.leading | 18 |
| abstract_inverted_index.notably | 15 |
| abstract_inverted_index.outcome | 174 |
| abstract_inverted_index.p=0.49) | 272 |
| abstract_inverted_index.p=0.59. | 256 |
| abstract_inverted_index.period. | 121 |
| abstract_inverted_index.present | 113 |
| abstract_inverted_index.primary | 173 |
| abstract_inverted_index.program | 74 |
| abstract_inverted_index.purpose | 53 |
| abstract_inverted_index.removed | 117 |
| abstract_inverted_index.review. | 97 |
| abstract_inverted_index.session | 125, 310 |
| abstract_inverted_index.sources | 233 |
| abstract_inverted_index.therapy | 109, 188, 248, 265 |
| abstract_inverted_index.treated | 49, 141 |
| abstract_inverted_index.updated | 322 |
| abstract_inverted_index.warning | 101 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Authors: | 332 |
| abstract_inverted_index.Patient, | 212 |
| abstract_inverted_index.changing | 302 |
| abstract_inverted_index.clinical | 281 |
| abstract_inverted_index.criteria | 167 |
| abstract_inverted_index.cultures | 290 |
| abstract_inverted_index.didactic | 123 |
| abstract_inverted_index.enrolled | 135 |
| abstract_inverted_index.evaluate | 59 |
| abstract_inverted_index.exposure | 9 |
| abstract_inverted_index.frequent | 232 |
| abstract_inverted_index.guidance | 26, 323 |
| abstract_inverted_index.isolated | 228 |
| abstract_inverted_index.low-risk | 46, 81, 146, 317 |
| abstract_inverted_index.medicine | 131 |
| abstract_inverted_index.organism | 148, 227 |
| abstract_inverted_index.outcomes | 182, 282 |
| abstract_inverted_index.patients | 137, 202 |
| abstract_inverted_index.positive | 289 |
| abstract_inverted_index.practice | 327 |
| abstract_inverted_index.pre-test | 114 |
| abstract_inverted_index.reported | 334 |
| abstract_inverted_index.therapy. | 24 |
| abstract_inverted_index.urinary. | 237 |
| abstract_inverted_index.(Serratia | 149 |
| abstract_inverted_index.Secondary | 181 |
| abstract_inverted_index.collected | 94 |
| abstract_inverted_index.described | 218 |
| abstract_inverted_index.developed | 295 |
| abstract_inverted_index.education | 124, 309 |
| abstract_inverted_index.exclusion | 166 |
| abstract_inverted_index.included: | 204 |
| abstract_inverted_index.inclusion | 164 |
| abstract_inverted_index.indicates | 29 |
| abstract_inverted_index.inducible | 106 |
| abstract_inverted_index.infection | 143 |
| abstract_inverted_index.morganii, | 152 |
| abstract_inverted_index.post-test | 89, 120 |
| abstract_inverted_index.potential | 104 |
| abstract_inverted_index.pre-test, | 88 |
| abstract_inverted_index.producing | 319 |
| abstract_inverted_index.reporting | 65, 304 |
| abstract_inverted_index.secondary | 280 |
| abstract_inverted_index.selection | 79, 315 |
| abstract_inverted_index.services. | 132 |
| abstract_inverted_index.treatment | 215 |
| abstract_inverted_index.vulgaris, | 154 |
| abstract_inverted_index.2.Serratia | 221 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 298 |
| abstract_inverted_index.Morganella | 151 |
| abstract_inverted_index.antibiotic | 78, 314 |
| abstract_inverted_index.definitive | 179, 187, 264 |
| abstract_inverted_index.difference | 242, 258, 276 |
| abstract_inverted_index.infection, | 213 |
| abstract_inverted_index.marcescens | 222 |
| abstract_inverted_index.mortality, | 194 |
| abstract_inverted_index.organisms. | 83, 320 |
| abstract_inverted_index.post-(81%) | 254 |
| abstract_inverted_index.production | 4, 36 |
| abstract_inverted_index.resistance | 22, 107 |
| abstract_inverted_index.treatment. | 180 |
| abstract_inverted_index.(3/21-2/22) | 159 |
| abstract_inverted_index.Disclosures | 330 |
| abstract_inverted_index.Providencia | 156 |
| abstract_inverted_index.ceftriaxone | 16 |
| abstract_inverted_index.combination | 300 |
| abstract_inverted_index.development | 20, 196 |
| abstract_inverted_index.disclosures | 335 |
| abstract_inverted_index.marcescens, | 150 |
| abstract_inverted_index.resistance. | 199, 297 |
| abstract_inverted_index.respiratory | 235 |
| abstract_inverted_index.significant | 241 |
| abstract_inverted_index.stewardship | 73 |
| abstract_inverted_index.(8/22-7/23). | 162 |
| abstract_inverted_index.hospitalized | 136 |
| abstract_inverted_index.microbiology | 64, 99, 303 |
| abstract_inverted_index.readmission, | 192 |
| abstract_inverted_index.retreatment, | 193 |
| abstract_inverted_index.β-lactamase | 3 |
| abstract_inverted_index.antimicrobial | 72 |
| abstract_inverted_index.collaboration | 69 |
| abstract_inverted_index.intervention, | 255 |
| abstract_inverted_index.antimicrobials, | 13 |
| abstract_inverted_index.characteristics | 216 |
| abstract_inverted_index.Enterobacterales | 42 |
| abstract_inverted_index.post-intervention | 161 |
| abstract_inverted_index.carbapenem-sparing | 178, 247 |
| abstract_inverted_index.post-intervention. | 211 |
| abstract_inverted_index.quasi-experimental | 90 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| citation_normalized_percentile.value | 0.03226664 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |